Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 1, 2014, Pages 25.e13-25.e20

  Erdem, Merve ^a   Erdem, Selcuk ^b   Sanli, Oner ^b   Sak, Halis ^a   Kilicaslan, Isin ^b   Sahin, Fikrettin ^a   Telci, Dilek ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Integrin 1; Metastasis; Renal cell carcinoma; Syndecan 4; Tissue transglutaminase

Indexed keywords

BETA1 INTEGRIN; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SYNDECAN 4; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SDC4 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CATALYSIS; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ITGB1 GENE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SDC4 GENE; TGM2 GENE; TUMOR NECROSIS; AGED; CELL SURVIVAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; KIDNEY TUMOR; METABOLISM; MIDDLE AGED; STATISTICAL MODEL; TUMOR CELL LINE; UPREGULATION;

AGED; ANTIGENS, CD29; CARCINOMA, RENAL CELL; CATALYSIS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; SYNDECAN-4; TRANSGLUTAMINASES; UP-REGULATION;

EID: 84890806130     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2012.08.022     Document Type: Article

References (22)

1. Pirrotta M.T., Bernardeschi P., Fiorentini G. Targeted-therapy in advanced renal cell carcinoma. Curr Med Chem 2011, 18(11):1651-1657.
2. Ljungberg B., Cowan N.C., Hanbury D.C., Hora M., Kuczyk M.A., Merseburger A.S., et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010, 58(3):398-406.
3. Kotsakis P., Griffin M. Tissue transglutaminase in tumour progression: friend or foe?. Amino Acids 2007, 33(2):373-384.
4. Choi Y., Chung H., Jung H., Couchman J.R., Oh E.S. Syndecans as cell surface receptors: unique structure equates with functional diversity. Matrix Biol 2011, 30(2):93-99.
5. Wang Z., Telci D., Griffin M. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex. Exp Cell Res 2011, 317(3):367-381.
6. Telci D., Wang Z., Li X., Verderio E.A., Humphries M.J., Baccarini M., et al. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling. J Biol Chem 2008, 283(30):20937-20947.
7. Belkin A.M. Extracellular TG2: emerging functions and regulation. FEBS J 2011, 278(24):4704-4716.
8. Collighan R.J., Griffin M. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids 2009, 36(4):659-670.
9. Verderio E.A., Telci D., Okoye A., Melino G., Griffin M. A novel RGD-independent cell adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis. J Biol Chem 2003, 278(43):42604-42614.
10. Mehta K., Fok J., Miller F.R., Koul D., Sahin A.A. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004, 10(23):8068-8076.
11. Chhabra A., Verma A., Mehta K. Tissue transglutaminase promotes or suppresses tumors depending on cell context. Anticancer Res 2009, 29(6):1909-1919.
12. Mangala L.S., Fok J.Y., Zorrilla-Calancha I.R., Verma A., Mehta K. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells. Oncogene 2007, 26(17):2459-2470.
13. Fok J.Y., Ekmekcioglu S., Mehta K. Implications of tissue transglutaminase expression in malignant melanoma. Mol Cancer Ther 2006, 5(6):1493-1503.
14. Moch H., Artibani W., Delahunt B., Ficarra V., Knuechel R., Montorsi F., et al. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma. Eur Urol 2009, 56(4):636-643.
15. Wang Z., Collighan R.J., Gross S.R., Danen E.H., Orend G., Telci D., et al. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 and {alpha} 5 {beta} 1 integrin co-signaling. J Biol Chem 2011, 285(51):40212-40229.
16. Slaughter T.F., Achyuthan K.E., Lai T.S., Greenberg C.S. A microtiter plate transglutaminase assay utilizing 5-(biotinamido)pentylamine as substrate. Anal Biochem 1992, 205(1):166-171.
17. Verderio E., Nicholas B., Gross S., Griffin M. Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res 1998, 239(1):119-138.
18. Beauvais D.M., Rapraeger A.C. Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2004, 2:3.
19. Shibue T., Weinberg R.A. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Nat Acad Sci USA 2009, 106(25):10290-10295.
20. Jones R.A., Kotsakis P., Johnson T.S., Chau D.Y., Ali S., Melino G., et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 2006, 13(9):1442-1453.
21. Telci D., Griffin M. Tissue transglutaminase (TG2)-a wound response enzyme. Front Biosci 2006, 11:867-882.
22. Kumar A., Gao H., Xu J., Reuben J., Yu D., Mehta K. Evidence that aberrant expression of tissue transglutaminase promotes stem cell characteristics in mammary epithelial cells. PLOS ONE 2011, 6(6):e20701.